Online citations, reference lists, and bibliographies.
← Back to Search

Risk Factors For Progressive Supranuclear Palsy

P. Davis, L. Golbe, Roger C. Duvoisin, MD, B. Schoenberg
Published 1988 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
To explore possible risk factors for progressive supranuclear palsy (PSP), we conducted a case-control study of 50 cases in New Jersey. Two neurologists confirmed the diagnosis in the 41 living patients. Two hospital controls were matched by age, sex, race, date of death, and relationship of next-to-kin to each case. A structured interview was administered in person to the next-of-kin of cases and controls. Genetic, viral, toxic, medical, surgical, and personality factors were investigated. Cases lived in areas with low population as adults significantly more frequently than controls. The study identified no other factors associated with PSP including a history of stroke, hypertension, or smoking.
This paper references
10.1093/OXFORDJOURNALS.AJE.A113621
Information available from surrogate respondents in case-control interview studies.
L. W. Pickle (1983)
10.1097/00005072-197401000-00007
NEUROFIBRILLARY TANGLES IN PROGRESSIVE SUPRANUCLEAR PALSY: ELECTRON MICROSCOPIC OBSERVATIONS
H. Powell (1974)
Etiology of Parkinson's disease: environmental factors
AH Rajput (1984)
10.1002/ANA.410150406
Alzheimer's disease: A study of epidemiological aspects
A. Heyman (1984)
Influence of environmental factors on the onset of Parkinson’s disease
CM Tanner (1986)
10.1016/0021-9681(79)90012-2
Bias in analytic research.
D. Sackett (1979)
10.1007/BF00684775
Electron microscopic study of neurofibrillary tangles in Steele-Richardson-Olszewski syndrome
S. Roy (2004)
Cigarette smoking and Parkinson’s disease. I. A comparison of cases with matched neighbors. Neurology 1980;30839-843
RJ Baumann (1980)
F'rwale~~ and natural history of progressive supranuclear palsy
L I Gobe
10.1212/WNL.36.2.284
A case‐control study of twin pairs discordant for Parkinson's disease
N. Bharucha (1986)
The clinical features and natural history of the Steele-Richardson-Olszewski syndrome
E R Maher (1986)
10.1212/WNL.37.2.226
A case‐control study of smoking habits, dementia, and other illnesses in idiopathic Parkinson's disease
A. Rajput (1987)
Influence of environmental factors on the onset of Parkinson's disease (PD)
C M Tanner (1986)
Progressive supranuclear palsy and a multi-infarct state. Neurology 1987;37:570-576
RM Dubinsky (1987)
10.1212/WNL.37.4.570
Progressive supranuclear palsy and a multi‐infarct state
R. Dubinsky (1987)
10.1002/ANA.410130308
Progressive supranuclear palsy: Clinical features and response to treatment in 16 patients
J. A. Jackson (1983)
10.1212/WNL.35.10.1483
Creutzfeldt‐Jakob disease
Z. Davanipour (1985)
10.1212/WNL.36.7.1005
The clinical features and natural history of the Steele‐Richardson‐Olszewski syndrome (progressive supranuclear palsy)
E. Maher (1986)
A case-control study of smoking habits, dementia, and other illnesses in idiopathic Parkinson's disease in Rochester
A H Rajput (1986)
10.1002/ANA.410180504
Progressive supranuclear palsy: Relationship between extrapyramidal disturbances, dementia, and brain neurotransmitter markers
S. Kish (1985)
10.1136/jnnp.45.7.577
Smoking and Parkinson's disease.
R. Godwin-Austen (1982)
10.1212/WNL.30.8.839
Cigarette smoking and Parkinson disease
R. J. Baumann (1980)
Head injury m a risk factor for Alzheimer’s disease
JA Mortimer (1985)
10.1002/ANA.410180503
Dopaminergic and cholinergic lesions in progressive supranuclear palsy
M. Ruberg (1985)
Atypical presentation of progreesive supranuclear palsy
PH Davia (1985)
10.1093/OXFORDJOURNALS.AJE.A120874
A retrospective study of smoking in Parkinson's disease.
M. Nefzger (1968)
10.1111/j.1600-0404.1985.tb03186.x
Progressive supranuclear palsy ‐ 20 years later
M. Kristensen (1985)
Models for the biochemical study of dementia
DR Crapper (1980)
10.1093/OXFORDJOURNALS.AJE.A113550
Should dead cases be matched to dead controls?
J. Kraus (1983)
Case-control studies: design, conduct, analysis. 1652 NEUROLOGY 38
J J Schlesselman
10.1016/0021-9681(69)90061-7
A short rating scale as a potential measure of pattern A behavior.
R. W. Bortner (1969)
10.2307/2288156
Case-Control Studies: Design, Conduct, Analysis
J. Schlesselman (1982)
Etiology of Parkinson's disease: environmental factors. Abstract
A H Rajput (1984)
Progressive supranuclear palsy. Brain 1972;95:693-704
JC Steele (1972)
10.1093/OXFORDJOURNALS.AJE.A121289
Epidemiologic studies of Parkinson's disease. I. Smoking and Parkinson's disease: a survey and explanatory hypothesis.
I. Kessler (1971)



This paper is referenced by
10.1136/pgmj.75.888.579
Progressive supranuclear palsy (Steele-Richardson-Olszewski disease)
H. Morris (1999)
10.1007/978-3-030-28852-5_13
Parkinson-Plus Syndromes
Cameron Miller-Patterson (2020)
10.1017/s0317167100038099
Progressive supranuclear palsy.
J. Jankovic (1987)
SYNAPTIC PLASTICITY AND THE NEUROBIOLOGICAL BASES OF LEARNING AND MEMORY
F. Benfenati (2009)
10.1016/S1353-8020(00)00011-0
The epidemiology of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome).
Nath (2000)
10.1212/WNL.0b013e3181a92bcc
Familial aggregation of parkinsonism in progressive supranuclear palsy
L. D. Kaat (2009)
10.1016/j.parkreldis.2019.07.036
Hypertension and progressive supranuclear palsy.
Soniya V Rabadia (2019)
10.1289/ehp.7567
Neurodegenerative Diseases: An Overview of Environmental Risk Factors
R. C. Brown (2005)
10.1002/mds.10562
Update on epidemiological aspects of progressive supranuclear palsy
I. Litvan (2003)
10.1136/jnnp.2008.149849
Risk factors for progressive supranuclear palsy: a case-control study in France
J. Vidal (2009)
10.1002/mds.10392
Lack of association between progressive supranuclear palsy and arterial hypertension: A clinicopathological study
C. Colosimo (2003)
10.1212/WNL.46.4.931
Autopsy-proven progressive supranuclear palsy in two siblings
J. Tetrud (1996)
10.1016/B978-1-4160-6641-5.00021-0
Progressive Supranuclear Palsy
H. Morris (2010)
10.1007/s100720170065
Epidemiology of progressive supranuclear palsy
N. Vanacore (2001)
10.1002/9781444341256.CH15
Progressive supranuclear palsy and corticobasal degeneration.
I. Litvan (1997)
10.1017/CBO9780511544873.045
Progressive Supranuclear Palsy.
L. Golbe (2001)
10.1007/BF03161076
Neuropathologic differentiation of progressive supranuclear palsy and corticobasal degeneration
D. Dickson (2009)
Parálisis supranuclear progresiva: aspectos neurológicos, neuropatológicos y neuropsicológicos
M. Gadea (1999)
10.1385/1-59259-834-X:023
Epidemiology of Progessive Supranuclear Palsy and Multiple System Atrophy
A. Zermansky (2005)
10.1016/S1353-8020(97)00022-9
Amantadine effectiveness in multiple system atrophy and progressive supranuclear palsy.
A. H. Rajrut (1997)
10.1212/WNL.54.1.114
Smoking habits in multiple system atrophy and progressive supranuclear palsy
N. Vanacore (2000)
10.1002/ana.20449
Genetic linkage of autosomal dominant progressive supranuclear palsy to 1q31.1
R. Ros (2005)
10.17511/IJMRR.2014.I05.16
Mickey Mouse sign and Humming Bird sign: Diagnostic Clue of Progressive Supranuclear Palsy
Diguvinti Sreeramulu (2014)
10.1016/S0072-9752(07)01242-0
The epidemiology of progressive supranuclear palsy.
L. Golbe (2008)
10.1001/ARCHNEUR.1988.00520360068014
Case-control study of early life dietary factors in Parkinson's disease.
L. Golbe (1988)
10.1515/tnsci-2016-0018
Cortical function in Alzheimer’s disease and frontotemporal dementia
P. Wang (2016)
10.1007/s00702-008-0030-y
Decreased blood–brain barrier P-glycoprotein function in the progression of Parkinson’s disease, PSP and MSA
A. Bartels (2008)
10.1007/S11940-001-0010-0
Progressive supranuclear palsy
L. Golbe (2006)
10.1016/B978-1-4377-2369-4.00009-3
Chapter 9 – Atypical parkinsonism, parkinsonism-plus syndromes, and secondary parkinsonian disorders
S. Fahn (2011)
10.1212/WNL.47.1.148
Follow-up study of risk factors in progressive supranuclear palsy
L. Golbe (1996)
10.1016/S0072-9752(07)01242-0
The epidemiology of progressive supranuclear palsy.
L. Golbe (1996)
10.1002/mds.26512
Environmental and occupational risk factors for progressive supranuclear palsy: Case‐control study
I. Litvan (2016)
See more
Semantic Scholar Logo Some data provided by SemanticScholar